{
  "id": "ed985fec6b317a3f",
  "title": "STAT+: EpiBiologics raises $107 million to develop bispecific antibodies against cancer and immune disorders",
  "description": "And more biotech news, brought to you by The Readout newsletter",
  "content": "And more biotech news, brought to you by The Readout newsletter",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/01/08/biotech-news-epibiologics-bispecific-antibodies-against-cancer/?utm_campaign=rss",
  "published_at": "2026-01-08T14:43:04+00:00",
  "fetched_at": "2026-01-09T00:23:18.491015+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: EpiBiologics raises $107 million to develop bispecific antibodies against cancer and immune disorders",
    "description": "And more biotech news, brought to you by The Readout newsletter",
    "url": "https://www.statnews.com/2026/01/08/biotech-news-epibiologics-bispecific-antibodies-against-cancer/?utm_campaign=rss",
    "published": "2026-01-08T14:43:04+00:00",
    "source": "STAT"
  }
}